Pharma Marketing Network

MARCH 19, 2025

This article explores the key metrics pharma marketing teams should prioritize to drive success. Unlike traditional consumer brands, pharmaceutical companies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

APRIL 24, 2025

This article explores emerging strategies, tech-driven innovations, regulatory watchpoints, and how marketers can leverage AI to optimize outcomes while building trust. According to McKinsey, 70% of pharmaceutical companies now use AI in marketing workflows. So, what does the new AI marketing frontier look like?

HIPAA 59

HIPAA FDA Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

MARCH 20, 2025

With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies HIPAA 59

Pharma Marketing Network

APRIL 25, 2025

This article explores how Integrated Marketing Communications (IMC) drives brand cohesion, regulatory clarity, and market growth within the pharmaceutical industry. For pharmaceutical companies, this means synchronizing communication across advertising, medical affairs, PR, social media, digital platforms, and sales.

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies HIPAA 59

Pharma Marketing Network

APRIL 4, 2025

This article explores the evolving role of referral marketing in pharma, unpacking its mechanics, benefits, compliance considerations, and future outlook. On the patient side, pharmaceutical companies have launched ambassador and mentorship programs. How do pharma companies use referral marketing?

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

APRIL 16, 2025

Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. In this article, we explore how data-driven marketing empowers pharma brands to be more precise, predictive, and effective in their outreach efforts.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

OCTOBER 6, 2021

Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. For pharmaceutical companies, this need is even more pressing.

HIPAA 98

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 98